Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
Study NCT ID:
NCT02988518
Status:
UNKNOWN
Last Update Posted:
2016-12-09
First Post:
2016-08-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints
Sponsor:
University Hospital, Montpellier
Organization:
Study Overview
Official Title:
Evaluation of a Cognitive Remediation Program on Patients With Bipolar Disorders, With Memory Complaints
Status:
UNKNOWN
Status Verified Date:
2016-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COGMED
Brief Summary:
Bipolar disorder is a major health concern. Intercritical periods are marked with residual symptoms, both thymic and cognitive, which affects quality of life of patients, but also the quality of observance. The implementation of cognitive remediation programs could be interesting. The aim of this study is to evaluate the overall performance on euthymic bipolar patients with memory complaints included in the program named "COGMED", targeting the working memory.
The impact of this program on compliance, quality of life, and memory complaints will be evaluated.
The investigator will measure whether there is a correlation between working memory and overall performances.
Finally, the investigator will try to achieve a profile of bipolar patients in whom the Cogmed program is particularly effective on a plan of overall performance.
The impact of this program on compliance, quality of life, and memory complaints will be evaluated.
The investigator will measure whether there is a correlation between working memory and overall performances.
Finally, the investigator will try to achieve a profile of bipolar patients in whom the Cogmed program is particularly effective on a plan of overall performance.
Detailed Description:
Patients with bipolar disorder and memory complaints will be recruited.
Two visits :
1. at baseline (V0) : the investigator evaluate bipolar disorder, treatment, mood, quality of life, global functioning, and memory complaints. Patients also have a neuropsychological assessment. The COGMED program is proposed to patients with memory complaints and explain by the investigator
2. 4-6 weeks after the end of the program (11-13 weeks after V1) : the same evaluation is realized to compare score before and after the program of cognitive remediation.
Between the two visits the patient will benefit of COGMED program, at home, during 5 weeks.
COGMED is a remediation cognitive program, based on working memory, consisting on daily exercises at home on a computer.
Two visits :
1. at baseline (V0) : the investigator evaluate bipolar disorder, treatment, mood, quality of life, global functioning, and memory complaints. Patients also have a neuropsychological assessment. The COGMED program is proposed to patients with memory complaints and explain by the investigator
2. 4-6 weeks after the end of the program (11-13 weeks after V1) : the same evaluation is realized to compare score before and after the program of cognitive remediation.
Between the two visits the patient will benefit of COGMED program, at home, during 5 weeks.
COGMED is a remediation cognitive program, based on working memory, consisting on daily exercises at home on a computer.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2014-A00825-42 | OTHER | Agence nationale de Sécurité des Médicaments | View |